NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

On October 13, 2023 were told we would get an update when the application was in the publisher’s hands and not when it was only partially in their hands. We were told this would be followed by announcement of submission to MHRA.

The reason for NWBO saying this would have been to address the concern of an open ended process with no clear milestones.

The ‘in the hands of the publisher’ PR should have let us say “Okay, for real, the clock is at least ticking on submission to MHRA with no more bullshit.”

Instead this the ‘majority of the application’ crap we are still abandoned in uncharted territory by this management team.

What does majority mean?

Is the time that the remaining part takes less or a lot more than the parts already given to the publisher?

Is the missing piece creating bottlenecks at the publisher?

I know you’re in the tank for management and if we were waiting on submission to MHRA in 2024 you’d still be excusing this stuff but can you at least see why many shareholders are rightly fed up with this decade of stringing along?